论文部分内容阅读
美国越来越多的生物技术公司都打算在国外进行一些仔细考虑过的室外释放试验。俄勒冈州立大学和费城一所有名的 Wistar 研究所今年分别在新西兰和阿根廷,对经遗传操作了的动物菌苗进行了现场试验。在这两项试验中,来自不相关病毒的抗原在作为寄主的牛痘病毒中得到了表达。不出所料,负责华盛顿经济动向基金会的 Jeremy Rifkin 就两种情况提出诉讼加以威胁。负责白宫生物技术政策研究小组的 David T.Kingsbury(国家科学基金会的一名生物学家)强调说,这是 Rifkin 以诉讼进行的一种经常性威胁,并伴随着不利的宣传手段,这不
More and more biotech companies in the United States are planning to conduct some carefully considered outdoor release tests abroad. This year, Oregon State University and a well-known Wistar Institute in Philadelphia conducted field tests on genetically manipulated animal vaccines in New Zealand and Argentina. In both tests, antigens from unrelated viruses were expressed in the vaccinia virus as host. Not surprisingly, Jeremy Rifkin, who is responsible for the Washington Economics Foundation, filed suit in two cases to threaten. David T. Kingsbury (a biologist at the National Science Foundation), responsible for the White House’s biotechnology policy research group, emphasized that this is a recurring threat to Rifkin’s litigation and accompanied by unfavorable propaganda.